期刊文献+

老年患者341例抗精神病用药分析 被引量:7

Prescription analysis of 341 elderly patients with antipsychotics
下载PDF
导出
摘要 目的:了解老年患者抗精神病药物的使用情况,为合理用药和科学管理提供参考。方法:收集60周岁以上精神分裂症患者341例,对其抗精神病药物的使用情况进行统计分析。结果:非典型抗精神病药已占据主导地位(92.96%),使用抗精神病药物数量由大到小依次是奥氮平(49.27%)、利培酮(19.35%)、富马酸喹硫平(19.06%)、阿立哌唑(15.25%)、氯氮平(7.92%)。联合用药出现频率最高的是奥氮平+阿立哌唑,辅助用药使用最多的是丙戊酸镁缓释片。结论:对于60岁以上的老年患者,大多使用非典型抗精神病药,不良反应较少。单一药物使用是最有效的治疗方案,其次是联合用药。 Objective:To understand the clinical use of antipsychotics in elderly patients in Xi’an Mental Health Center,and to provide reference for rational drug use and scientific management.Methods:A total of 341 patients with schizophrenia over 60 years of age were collected,and their use of antipsychotic drugs was statistically analyzed.Results:Atypical antipsychotics had occupied dominant position(92.96%).The number of antipsychotic drugs used in descending order were olanzapine(49.27%),risperidone(19.35%),quetiapine fumarate(19.06%),aripiprazole(15.25%),clozapine(7.92%).The highest frequency of combined drug use was olanzapine+ aripiprazole,and the most used adjuvant drug was magnesium valproate sustained release tablets.Conclusion:For the elderly patients over 60 years old,atypical antipsychotics with less adverse reactions are recommended.Single drug use was the most therapeutic regimen,followed by drug combination.
作者 阎得胜 闫可域 祁婧 权伟 YAN Desheng;YAN Keyu;QI Jing(Xi’an Mental Health Center,Xi’an 710199;不详)
出处 《陕西医学杂志》 CAS 2020年第3期337-340,共4页 Shaanxi Medical Journal
基金 陕西省自然科学基础研究计划项目(2017JM8007).
关键词 精神分裂症 抗精神病药 处方 老年人 Schizophrenia Antipsychotic drugs Prescriptions Aged
  • 相关文献

参考文献6

二级参考文献35

  • 1周艳兰,陈新河,任赐儿.657张住院抗精神病药处方分析[J].广东药学,2004,14(3):61-62. 被引量:1
  • 2司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘.10省市抗精神病药使用现况的调查[J].中华精神科杂志,2004,37(3):152-155. 被引量:95
  • 3陈新谦 金有豫.新编药物学(第14版)[M].北京:人民卫生出版社,2000.382.
  • 4张聪沛,张延承,王琳,王莹,滕秀英,王怀政.维思通与氯氮平治疗精神分裂症对照分析[J].临床精神医学杂志,1997,7(2):74-75. 被引量:47
  • 5世界卫生组织.ICD-10精神与行为障碍分类,临床描述与诊断要点[M].北京:人民卫生出版社,1993.197-198.
  • 6Knights A,Hrish SR.Reveled depression and drug treatment for Schizophrenia[J].Areb Gene Psychinatry,1981,38:806-811.
  • 7Kan J.Hongfeld G,Singen,J,et al.Clozapine for the treatment of resistant Schizophrinia.Adouble-blind Compaeison with Clorpromazine[J].Arch Gen Psychiatry,1998,45:789.
  • 8舒良.精神分裂症防治指南[M].北京:北京大学医学出版社,2007:64.
  • 9Ganguly R, Kotzan JA, Miller LS, et al. Prevalence, trends, and factors associated with antipsychotic polypharmacy am- ong Medicaid-eligible schizophrenia patients, 1998-2000. Journal of Clinical Psychiatry, 2004, 65(10): 1377-88.
  • 10Clark RE, Bartels S J, Mellman TA, et al. Recent trends in antipsychotic combination therapy of schizophrenia and schizoaffective disorder: Implications for state mental health policy. Schizophrenia Bulletin, 2002, 28:75-84.

共引文献34

同被引文献110

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部